Legend Biotech Corp ADR (NASDAQ:LEGN) currently has a daily average trading volume of 1.33M but it saw 577907 shares traded in last market. With a market cap of 7.11B USD, the company’s current market price of $38.75 came rising about 1.39 while comparing to the previous closing price of $38.22. In past 52 weeks, the stock remained buoying in the range of price level as high as $70.13 and as low as $30.17.
Taking a look at 20-day trading activity of Legend Biotech Corp ADR (LEGN) gives us an average price of $36.83, while its current price level is -44.75% below from 52-week high level whereas it is 28.44% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $35.45 while that of 200 days or SMA-200 reads an average of $44.71. A closer look into the stock’s movement over the week reveals that its volatility is standing at 4.61% during that period while stretching the period over a month that increases to 5.00%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 61.48 which implies that the stock is in neutral territory.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Redburn Atlantic which initiated the stock as “Buy” in its note to investors issued on October 08, 2024, recommending a price target of $86 for it. H.C. Wainwright issued its recommendations for the stock as it reiterated the price target for the stock in the range of between $86 and $73.
Over the week, LEGN’s stock price is moving 11.90% up while it is 18.65% when we observe its performance for the past one month. Year-to-date it is 19.08% up and over the past year, the stock is showing a downside performance of -32.08%.
The company is expected to be releasing its next quarterly report in March, for which analysts forecasted an EPS of -0.38 while estimate for next year EPS is -1.4. In next quarter, company is expected to be making quarterly sales of $195.69M as analysts are expecting the sales for current fiscal year at $615.52M and seeing the company making $1.01B in sales next year. Moreover, analysts are in estimates of $179M for current-quarter revenue.
Currently, Legend Biotech Corp ADR’s total number of outstanding shares is 183.45M with 1.32% of that held by the insiders while 55.61% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -23.87% and return on equity (ROE) at -28.35%. Stock’s beta reads 0.18. Stock has a price to book (P/B) ratio of 6.37 while price to sale or P/S ratio amounts to 13.67. Its return on asset (ROA) is -19.47% on average.
